|
| Press Releases |
|
 |
|
| Monday, August 28, 2023 |
|
|
金活医药中期公司拥有人应占溢利同比增长55.8% |
| 医药大健康分销领先企业—金活医药集团有限公司（「金活医药」或「集团」，股份代号：01110.HK）欣然公布其截至2023年6月30日止六个月(「报告期内」或「上半年」)未经审核之中期业绩。 more info >> |
|
|
金活醫藥中期公司擁有人應占溢利同比增長55.8% |
| 醫藥大健康分銷領先企業—金活醫藥集團有限公司（「金活醫藥」或「集團」，股份代號：01110.HK）欣然公佈其截至2023年6月30日止六個月(「報告期內」或「上半年」)未經審核之中期業績。 more info >> |
|
|
Net Profit of Kingworld Medicines Increased By 55.8% |
| Kingworld Medicines Group Limited ("Kingworld Medicines" or the "Group", stock code: 01110.HK), a leading healthcare distribution company, announced its unaudited interim results for the year ended 30 June 2023 (the "Reporting Period" or the "First Half of 2023") . more info >> |
|
| Wednesday, August 16, 2023 |
|
|
金活医药优化产业布局 进一步认购大幸药业2.08%股权 |
| 医药大健康分销领先企业—金活医药集团有限公司（「金活医药」或「集团」，股份代号：01110.HK）于15日公布，金活医药将进一步认购日本大幸药品株式会社（「大幸药品」，股票代码：4574.JP） more info >> |
|
|
金活醫藥優化產業佈局 進一步認購大幸藥業2.08%股權 |
| 醫藥大健康分銷領先企業—金活醫藥集團有限公司（「金活醫藥」或「集團」，股份代號：01110.HK）於15日公佈，金活醫藥將進一步認購日本大幸藥品株式會社（「大幸藥品」，股票代碼：4574.JP） more info >> |
|
|
Kingworld Further Subscribed For 2.08% Equity of Taiko Pharmaceutical To Optimize Its Layout of Pharmaceutical Industry |
| Kingworld Medicines Group Limited ("Kingworld Medicines" or the "Group", stock code: 01110.HK), a leading healthcare distribution company, announced on 15th that the Group plans to further subscribe for the shares of Taiko Pharmaceutical Co., Ltd. more info >> |
|
| Wednesday, August 2, 2023 |
|
|
金活医药预期上半年溢利增长35%至40% |
| 医药大健康分销领先企业—金活医药集团有限公司（「金活医药」或「集团」，股份代号：01110.HK）欣然公布，基于本集团截至2023年6月30日止的未经审核综合管理账目及董事会目前可得的资料之初步评估，预期2023年上半年的溢利将较去年同期增加约35%至40%。 more info >> |
|
|
金活醫藥預期上半年溢利增長35%至40% |
| 醫藥大健康分銷領先企業—金活醫藥集團有限公司（「金活醫藥」或「集團」，股份代號：01110.HK）欣然公布，基於本集團截至2023年6月30日止的未經審核綜合管理賬目及董事會目前可得的資料之初步評估，預期2023年上半年的溢利將較去年同期增加約35%至40%。 more info >> |
|
|
Kingworld Medicines Expects 1H Profit Increased By 35%-40% |
| Kingworld Medicines Group ("Kingworld Medicines" or the "Group", stock code: 01110.HK), a leading healthcare distribution company, announced a projected rise in profit for the first half of the fiscal year. more info >> |
|
| Tuesday, April 25, 2023 |
|
|
持續拓展上游供應鏈 金活醫藥參股日本大幸藥品 |
| 2023年4月24日，醫藥大健康分銷領先企業——金活醫藥集團有限公司（「金活醫藥」或「集團」，股份代碼：01110.HK）公告，集團同意認購日本大幸藥品株式會社（「大幸藥品」，股票代碼：4574.JP）2,178,400股股份，佔大幸藥品經擴大已發行股本的約4.68%，總代價為832,148,800日元（約48,431,060港元）。 more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
富士通フィンランド、電気自動車向け充電ソリューションを提供するKempower様に包括的なITサービスを提供
Dec 5, 2023 11:00: JST
|
|
|
透云生物引领餐饮界新「潮流」 莱茵衣藻获逾百家知名餐饮品牌及米芝莲餐厅入馔
Dec 5, 2023 10:00 HKT/SGT
|
|
|
透雲生物引領餐飲界新「潮流」 萊茵衣藻獲逾百家知名餐飲品牌及米芝蓮餐廳入饌
Dec 5, 2023 09:59 HKT/SGT
|
|
|
Fujitsu Finland to provide comprehensive IT services to Kempower, provider of electric vehicle fast charging solutions
Dec 5, 2023 10:52 JST
|
|
|
Reach Announces Platform-Agnostic Global Tax Compliance Solution
Dec 5, 2023 08:00 HKT/SGT
|
|
|
BluWave-ai and Dubai Taxi Corporation Debut AI Optimization of EV Fleet
Dec 5, 2023 05:00 HKT/SGT
|
|
|
AJ Issenman Joins AELF FlightService as Director of Capital Markets
Dec 4, 2023 23:00 HKT/SGT
|
|
|
China Medical System: NDA for Additional RA Indication of Methotrexate Injection Accepted in China
Dec 4, 2023 22:52: JST
|
|
|
China Medical System: NDA for Additional RA Indication of Methotrexate Injection Accepted in China
Dec 4, 2023 21:49 HKT/SGT
|
|
|
SolidusMarkets Reports on 'Global Inflation Landscape and Impacts on Asset Classes'
Dec 4, 2023 21:26: JST
|
|
|
Wiz Acquires Raftt, Bolsters CNAPP Offering for Cloud and Kubernetes Developers
Dec 4, 2023 21:00 HKT/SGT
|
|
|
Atlas Lithium在2024年首次生產前已獲得充分資金支持
Dec 4, 2023 21:00 HKT/SGT
|
|
|
Atlas Lithium在2024年首次生产前已获得充分资金支持
Dec 4, 2023 21:00 HKT/SGT
|
|
|
Atlas Lithium Fully Funded to First Production in 2024
Dec 4, 2023 21:00 HKT/SGT
|
|
|
Q2 Metals Receives Proceeds of $2.0 Million from Shareholder Warrant Exercises
Dec 4, 2023 20:39 HKT/SGT
|
|
|
|
|
More News >> |
|
|
|
|
|
